Axsome Therapeutics's total assets for Q3 2025 were $669.25M, an increase of 4.61% from the previous quarter. AXSM total liabilities were $595.52M for the fiscal quarter, a 5.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.